Inventor · disambiguated record
Lei Chang
Also filed as: CHANG LEI
13 granted patents·20 pending applications·122 citations·filing 2002–2025
91Inventor score
Files withUNIV NORTHWESTERN9QUANTERIX CORP7ACTON PAUL2GLOBAL HEALTH DRUG DISCOVERY INST2KLEIN WILLIAM L2
Top patents by PatentIndex Score
33 records- 0197US9678068B2Ultra-sensitive detection of molecules using dual detection methodsDUFFY DAVID C·Filed 2010·Granted Jun 13, 2017·64 cites·30 claims
- 0292US7780963B2Anti-ADDL antibodies and uses thereofMERCK & CO INC·Filed 2005·Granted Aug 24, 2010·25 cites·14 claims
- 0389US12130294B2Quantification of biomarkers present in physiological samplesQUANTERIX CORP·Filed 2019·Granted Oct 29, 2024·4 cites·16 claims
- 0489US12111324B2Quantification of biomarkers present in dried physiological samplesQUANTERIX CORP·Filed 2019·Granted Oct 8, 2024·4 cites·15 claims
- 0587US7811563B2Anti-addl antibodies and uses thereofUNIV NORTHWESTERN·Filed 2005·Granted Oct 12, 2010·9 cites·14 claims
- 0682US11686730B2Quantitative antibody testQUANTERIX CORP·Filed 2021·Granted Jun 27, 2023·1 cites·21 claims
- 0781US8383113B2Anti-ADDL antibodies and uses thereofUNIV NORTHWESTERN·Filed 2012·Granted Feb 26, 2013·4 cites·12 claims
- 0877US2025341530A1Quantification of neurofilament light chain in physiological samplesQUANTERIX CORP·Filed 2025·Application pending·0 cites
- 0976US8889138B2Anti-ADDL antibodies and uses thereofACTON PAUL·Filed 2010·Granted Nov 18, 2014·3 cites·12 claims
- 1076US8128930B2Anti-ADDL antibodies and uses thereofACTON PAUL·Filed 2010·Granted Mar 6, 2012·3 cites·13 claims
- 1169US2021386879A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2021·Application pending·0 cites
- 1268US12287343B2Quantification of neurofilament light chain in physiological samplesQUANTERIX CORP·Filed 2019·Granted Apr 29, 2025·0 cites·19 claims
- 1367US9518066B2GAK modulatorsUNIV LEUVEN KATH·Filed 2014·Granted Dec 13, 2016·1 cites·12 claims
- 1464US8507206B2Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)LAMBERT MARY P·Filed 2005·Granted Aug 13, 2013·4 cites·1 claims
- 1562US2014322731A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2014·Application pending·0 cites
- 1661US2017209604A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2017·Application pending·0 cites
- 1759US11548848B2Synthesis and application of alcohol amine with expended main carbon chainUNIV BEIJING TECHNOLOGY·Filed 2021·Granted Jan 10, 2023·0 cites·8 claims
- 1858US2009285804A1Anti-ADDLs antibodies and uses thereofKLEIN WILLIAM L·Filed 2009·Application pending·0 cites
- 1957US2016213794A1Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules and uses thereofUNIV NORTHWESTERN·Filed 2016·Application pending·0 cites
- 2056US2013150560A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 2156US2013236466A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 2255US2003068316A1Anti-ADDL antibodies and uses thereofFiled 2002·Application pending·0 cites
- 2354US2025262337A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2025·Application pending·0 cites
- 2454US2007048312A1Anti-ADDL antibodies and uses thereofKLEIN WILLIAM L·Filed 2006·Application pending·0 cites
- 2551US2022050106A1Methods and kits for detecting sars-coronavirus-2 antigenQUANTERIX CORP·Filed 2021·Application pending·0 cites
- 2647US2025214997A1Mettl3 inhibitor compound, and pharmaceutical composition and use thereofGLOBAL HEALTH DRUG DISCOVERY INST·Filed 2025·Application pending·0 cites
- 2747US2008176252A1Amyloid beta-derived diffusible ligands (ADDLs), ADDL-surrogates, ADDL-binding molecules, and uses thereofKRAFFT GRANT A·Filed 2005·Application pending·0 cites
- 2847US2025223307A1Mdm2/mdmx double-target inhibitor compound, prodrug, pharmaceutical composition, and preparation method therefor and use thereofGLOBAL HEALTH DRUG DISCOVERY INST·Filed 2025·Application pending·0 cites
- 2946US2020271643A1Methods and systems for the detection of analyte moleculesQUANTERIX CORP·Filed 2018·Application pending·0 cites
- 3046US2013330837A1Monoclonal antibodies that target pathological assemblies of amyloid beta (abeta)ACUMEN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3145US2005059634A1Per-6-substituted-per-6-deoxy-cyclodextrins, and use of the same to inhibit soluble beta-amyloid-peptide derived oligomers and to treat alzheimer's and related diseasesFiled 2004·Application pending·0 cites
- 3233US2008306074A1Compositions Comprising Addl Receptors, Related Compositions, and Related MethodsLACOR PASCALE N·Filed 2005·Application pending·0 cites
- 3328US2013217147A1Detection of complexes of tau and amyloidGIBBONS WINTON G·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lei Chang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →